Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
144.00    -1.00 (-0.69%)
Bid:
144.00
Ask:
145.00
Spread: 1.00 (0.694%)
Market Cap: £113.00m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

PACKAGING PROGRESS UPDATE

3 Oct 2013 07:00

RNS Number : 6006P
Xaar PLC
03 October 2013
 



 

3 October 2013

 

 

Xaar plc

 

 

PACKAGING PROGRESS UPDATE

 

 

Xaar plc ("Xaar", "the Group" or "the Company"), the inkjet printing technology Group headquartered in Cambridge, is pleased to issue an update on recent progress made in developing new opportunities in the packaging sector.

 

Xaar's market leading technology is at the heart of multiple innovative digital inkjet packaging solutions which were launched or demonstrated by Xaar's OEM partners at major exhibitions during September 2013.

 

· At Print 13 (8-12th September, Chicago) FFEI Ltd, a leading developer, manufacturer and supplier of digital imaging solutions, launched its new-generation Graphium digital UV inkjet printer. The product will be distributed by Fujifilm in both the USA and Europe. Xaar 1001 printheads were specified by FFEI to deliver the high productivity, reliability and quality that customers require for label, packaging and speciality print applications.

 

· At DRINKTEC (16-20th September 2013, Munich) four of Xaar's partner OEMs publicly demonstrated for the first time innovative "direct-to-shape" digital printing solutions. The four OEMs demonstrated systems which enable full colour images and text to be digitally printed directly onto glass, PET and metal containers, creating significant efficiencies through reductions in materials and inventory, improving time to market and eliminating many of the costs associated with using labels or sleeves. In addition, this technology allows digital decoration of irregular-shaped and textured containers which can pose a challenge for traditional labels and sleeves. It is expected that these offerings will now undergo a number of field trials which, if successful, will lead to the commercialisation of the technology.

 

· At Labelexpo Europe (24-27th September 2013, Brussels), Xaar's partner OEMs including ALS Engineering, Durst, EFI Jetrion, FFEI/Fujifilm, INX International, JF Machines and Stork Prints, all demonstrated their latest Xaar 1001-enabled labelling solutions which range from stand-alone entry-level systems for late-stage overprinting, to fully integrated systems for in-line graphics digital printing and finishing.

 

For further detail on these and other developments please go to www.xaar.com/news.aspx to access Xaar's latest news releases.

 

Ian Dinwoodie, Xaar's Chief Executive, commented:

 

"It is pleasing to see the progress being made in this significant market. Digital print of full colour graphic labels is clearly gaining traction in the packaging industry as evidenced by the strength of our OEMs' product line-up recently exhibited. The first public 'direct-to-shape' demonstrations clearly created an industry buzz, and we look forward to our partners moving through their field trials and into commercialisation. Whilst this recent activity is not expected to have any material impact on Xaar's 2013 financial results, the positive feedback received reinforces the potential for Xaar's technology to create transformational and disruptive solutions across multiple discrete markets".

 

END

 

 

 

Xaar plc:

01223-423663

Ian Dinwoodie, Chief Executive

Alex Bevis, Finance Director

Bankside Consultants:

020-7367-8888

Simon Bloomfield

Fiona Scholes

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFSAESEFDSESS
Date   Source Headline
8th Dec 20069:43 amRNSRule 2.10 Announcement
7th Dec 20067:01 amRNSTrading Update for FY 2006
6th Dec 20061:08 pmRNSEPT Disclosure
4th Dec 20064:14 pmRNSEPT Disclosure-Amendment
4th Dec 20063:43 pmRNSHolding(s) in Company
4th Dec 200611:30 amRNSEPT Disclosure
1st Dec 20066:48 pmRNSEPT Disclosure-Amendment
1st Dec 200612:12 pmRNSEPT Disclosure
30th Nov 200612:20 pmRNSEPT Disclosure
29th Nov 200612:13 pmRNSEPT Disclosure
27th Nov 200612:34 pmRNSEPT Disclosure
23rd Nov 20069:18 amRNSRule 2.10 Announcement
21st Nov 20062:49 pmRNSRule 8.3- Xaar PLC
21st Nov 200612:35 pmRNSEPT Disclosure
21st Nov 20069:14 amRNSHolding(s) in Company
20th Nov 200612:18 pmRNSEPT Disclosure
17th Nov 200612:17 pmRNSEPT Disclosure
17th Nov 20067:00 amRNSHolding(s) in Company
16th Nov 200612:24 pmRNSEPT Disclosure
14th Nov 20064:39 pmRNSStatement re Xaar plc
14th Nov 20062:58 pmRNSStatement re Possible Offer
9th Nov 20064:39 pmRNSHolding(s) in Company
1st Nov 20067:00 amRNSHolding(s) in Company
26th Oct 20067:00 amRNSHolding(s) in Company
25th Sep 20066:06 pmRNSHolding(s) in Company
18th Sep 20067:00 amRNSHolding(s) in Company
15th Sep 20066:29 pmRNSHolding(s) in Company
13th Sep 20067:01 amRNSInterim Results
31st Aug 20061:40 pmRNSHolding(s) in Company
30th Aug 20062:00 pmRNSNotice of Interim Results
21st Aug 20063:09 pmRNSHolding(s) in Company
11th Aug 20068:39 amRNSHolding(s) in Company
9th Aug 20067:00 amRNSTrading Update
17th Jul 20066:31 pmRNSHolding(s) in Company
17th Jul 20066:25 pmRNSHolding(s) in Company
14th Jul 20066:25 pmRNSHolding(s) in Company
4th Jul 20065:35 pmRNSHolding(s) in Company
3rd Jul 20067:00 amRNSHolding(s) in Company
30th Jun 20066:28 pmRNSHolding(s) in Company
13th Jun 20067:00 amRNSHolding(s) in Company
13th Jun 20067:00 amRNSHolding(s) in Company
19th May 20066:16 pmRNSHolding(s) in Company
19th May 20066:03 pmRNSHolding(s) in Company
19th May 20065:58 pmRNSHolding(s) in Company
19th May 20065:50 pmRNSHolding(s) in Company
19th May 20063:53 pmRNSDirector/PDMR Shareholding
16th May 20066:32 pmRNSDirector/PDMR Shareholding
15th May 20063:17 pmRNSHolding(s) in Company
12th May 20065:30 pmRNSDirector/PDMR Shareholding
12th May 20067:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.